Patents by Inventor Tomoyuki Hasegawa
Tomoyuki Hasegawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7820715Abstract: Crystals comprising (2R)-2-propyloctoic acid and an amine which retain the pharmacological effect of (2R)-2-propyloctoic acid and can be safely used as a medicinal raw drug for peroral solid preparations. Of these crystals, the crystals especially with dibenzylamine are advantageous because not only the crystals themselves are useful as a medicinal raw drug but also use of the crystals as an intermediate can yield (2R)-2-propyloctoic acid having an optical purity exceeding 99.5% e.e., which has not been obtained hitherto.Type: GrantFiled: April 27, 2005Date of Patent: October 26, 2010Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Tomoyuki Hasegawa, Yasufumi Kawanaka, Eiji Kasamatsu
-
Patent number: 7781360Abstract: The present invention provides a dielectric porcelain composition comprising 100 parts by weight of a barium titanate-based dielectric material and 4 to 10 parts by weight in total of Bi2O3 and at least one compound selected from the group of consisting of CuO, ZnO and MgO.Type: GrantFiled: September 4, 2008Date of Patent: August 24, 2010Assignees: NGK Insulators, Ltd., Soshin Electric Co., Ltd.Inventors: Tomoyuki Hasegawa, Yoshinori Ide, Tadashi Otagiri
-
Publication number: 20100149725Abstract: It is provided a ceramic multilayer substrate obtained by co-sintering a low dielectric constant layer made of an insulating material of a low dielectric constant and a high dielectric constant layer of a dielectric material of a high dielectric constant. The low dielectric constant layer includes a ceramic component of xBaO-yTiO2-zZnO (“x”, “y” and “z” represent molar ratios, respectively, and satisfy the relationship: x+y+z=1; 0.09?x?0.20; 0.49?y?0.61; 0.19?z?0.42) and 1.0 to 5.0 weight parts of a glass component comprising boron oxide with respect to 100 weight parts of the ceramic component. The high dielectric layer is made of a barium titanate based dielectric material with CuO and Bi2O3 added thereto.Type: ApplicationFiled: March 1, 2010Publication date: June 17, 2010Applicants: Soshin Electric Co., Ltd., NGK Insulators, Ltd.Inventors: Tomoyuki HASEGAWA, Takashi NAGATOMO, Yoshinori IDE, Tadashi OTAGIRI
-
Publication number: 20100087244Abstract: While one video reel is being scrolled and the remaining video reels stop scrolling, a map of Japan or a map of America is displayed on a liquid crystal panel. A territory corresponding to a player is distinguished by color on the map. There is a correlation in terms of probability between the territory corresponding to the player distinguished by color and a payout amount corresponding to a symbol combination to be realized upon stop of scroll of all the video reels.Type: ApplicationFiled: October 8, 2009Publication date: April 8, 2010Applicant: ARUZE GAMING AMERICA, INC.Inventors: Mitsuhiro TAKEDA, Takeshi AOKI, Tomoyuki HASEGAWA, Shintarou OKAZAWA, Tsuyoshi OHIRA, Takanori SAKATA, Hiroki ABE
-
Publication number: 20100069141Abstract: A gaming machine of the present invention performs an effect of rotating an image displayed in each display block having a second specific symbol rearranged therein in a direction so as to turn a display screen of a display over to the other side after scroll-displaying a specific character image to the display in a direction from one side of a symbol display region toward the opposite side, and also changing the second specific symbol rearranged in the each display block into a first specific symbol, when the first specific symbol and the second specific symbol have been rearranged in the symbol display region and also when it has been determined to display the specific character image; and offers an award in accordance with the number of first specific symbols arranged in the symbol display region as a result thereof.Type: ApplicationFiled: March 27, 2009Publication date: March 18, 2010Applicant: Aruze Gaming America, Inc.Inventors: Mitsuhiro Takeda, Eri Dobashi, Tomoyuki Hasegawa, Takeshi Aoki, Shintarou Okazawa
-
Patent number: 7589221Abstract: The present invention relates to a process for producing (2R)-2-propyloctanoic acid, which comprises subjecting (2R)-2-hexyloxirane to a two-carbon adding reaction with ring-opening reaction, followed by a protecting reaction of a hydroxyl group to convert it to a compound represented by formula (I): (wherein X represents an optionally protected hydroxyl group) and then subjecting the compound to a one-carbon adding reaction to convert it to (2R)-2-propyloctanamide, followed by recrystallization and hydrolysis. According to the process of the present invention, (2R)-2-propyloctanoic acid can be produced by less steps as compared with the conventional method without a dangerous reaction.Type: GrantFiled: June 9, 2004Date of Patent: September 15, 2009Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Yasumasa Hamada, Tomoyuki Hasegawa, Toshiaki Matsui, Eiji Kasamatsu
-
Patent number: 7579375Abstract: The present invention relates to a compound represented by formula (I) wherein R1 represents optionally protected hydroxy or oxo, indicates ?-configuration, ?-configuration or a mixture of these in an arbitrary proportion, n represents an integer of 1 to 3, and m represents 0 or an integer of 1 to 10; and wherein two or more R1's are not bound to the same carbon atom other than the terminal carbon atom, a salt thereof or a prodrug thereof. The compounds represented by formula (I) have an ability to improve astrocyte function, and they are useful as a preventive and/or therapeutic agent for a brain infarction, neuronal dysfunction by brain infarction, Parkinson's disease, Parkinson's syndrome, amyotrophic lateral sclerosis or Alzheimer's disease.Type: GrantFiled: July 14, 2004Date of Patent: August 25, 2009Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Haruo Imawaka, Tomoyuki Hasegawa, Shigeru Sakuyama, Yasufumi Kawanaka, Tsutomu Akiyama, Masamitsu Hoshikawa, Saiko Matsuda
-
Patent number: 7540427Abstract: The present invention provides an IC tag which has a structure comprising a first adhesive layer formed on a surface of a substrate sheet, an electronic circuit and an IC chip connecting both ends of the electronic circuit, both formed on the surface of the first adhesive layer, and a second adhesive layer covering the electronic circuit and the IC chip. The IC tag further includes a release agent layer formed at positions corresponding to the both ends of the electronic circuit and located at the interface between the substrate sheet and the first adhesive layer. When the IC tag attached to an article is peeled off, the built-in electronic circuit is surely broken.Type: GrantFiled: May 14, 2003Date of Patent: June 2, 2009Assignee: Lintec CorporationInventors: Masateru Yamakage, Katsuhisa Taguchi, Tomoyuki Hasegawa, Toru Takahara
-
Publication number: 20090011923Abstract: The present invention provides a dielectric porcelain composition comprising 100 parts by weight of a barium titanate-based dielectric material and 4 to 10 parts by weight in total of Bi2O3 and at least one compound selected from the group of consisting of CuO, ZnO and MgO.Type: ApplicationFiled: September 4, 2008Publication date: January 8, 2009Applicants: NGK Insulators, Ltd., Soshin Electric Co., Ltd.Inventors: Tomoyuki Hasegawa, Yoshinori Ide, Tadashi Otagiri
-
Publication number: 20080090907Abstract: Crystals comprising (2R)-2-propyloctoic acid and an amine which retain the pharmacological effect of (2R)-2-propyloctoic acid and can be safely used as a medicinal raw drug for peroral solid preparations. Of these crystals, the crystals especially with dibenzylamine are advantageous because not only the crystals themselves are useful as a medicinal raw drug but also use of the crystals as an intermediate can yield (2R)-2-propyloctoic acid having an optical purity exceeding 99.5% e.e., which has not been obtained hitherto.Type: ApplicationFiled: April 27, 2005Publication date: April 17, 2008Applicant: ONO PHARMACEUTICAL CO., LTD.Inventors: Tomoyuki Hasegawa, Yasufumi Kawanaka, Eiji Kasamatsu
-
Publication number: 20070167522Abstract: The present invention relates to a compound represented by formula (I) wherein R1 represents optionally protected hydroxy or oxo, indicates ?-configuration, ?-configuration or a mixture of these in an arbitary proportion, n represents an integer of 1 to 3, and m represents 0 or an integer of 1 to 10; and wherein two or more R1's are not bound to the same carbon atom other than the terminal carbon atom, a salt thereof or a prodrug thereof. The compounds represented by formula (I) have an ability to improve astrocyte function, and they are useful as a preventive and/or therapeutic agent for a brain infarction, neuronal dysfunction by brain infarction, Parkinson's disease, Parkinson's syndrome, amyotrophic lateral sclerosis or Alzheimer's disease.Type: ApplicationFiled: July 14, 2004Publication date: July 19, 2007Inventors: Haruo Imawaka, Tomoyuki Hasegawa, Shigeru Sakuyama, Yasufumi Kawanaka, Tsutomu Akiyama, Masamitsu Hoshikawa, Saiko Matsuda
-
Patent number: 7153852Abstract: Indole derivatives represented by formula (I) wherein all symbols represent the same as that in specification), production methods thereof, and DP receptor antagonist comprising them as active ingredients. Since the compounds of formula (I) binds and antagonizes to DP receptor, they are useful for the prevention and/or treatment against allergic diseases, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, cerebrovascular disorder, pleuritis complicated by rheumatoid arthritis, ulcerative colitis.Type: GrantFiled: September 6, 2002Date of Patent: December 26, 2006Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Kazuhiko Torisu, Tomoyuki Hasegawa, Kaoru Kobayashi, Fumio Nambu
-
Publication number: 20060273179Abstract: The present invention provides an IC tag which has a structure comprising a first adhesive layer formed on a surface of a substrate sheet, an electronic circuit and an IC chip connecting both ends of the electronic circuit, both formed on the surface of the first adhesive layer, and a second adhesive layer covering the electronic circuit and the IC chip. The IC tag further includes a release agent layer formed at positions corresponding to the both ends of the electronic circuit and located at the interface between the substrate sheet and the first adhesive layer. When the IC tag attached to an article is peeled off, the built-in electronic circuit is surely broken.Type: ApplicationFiled: May 14, 2003Publication date: December 7, 2006Inventors: Masateru Yamakage, Katsuhisa Taguchi, Tomoyuki Hasegawa, Toru Takahara
-
Publication number: 20060135802Abstract: The present invention relates to a process for producing (2R)-2-propyloctanoic acid, which comprises subjecting (2R)-2-hexyloxirane to a two-carbon adding reaction with ring-opening reaction, followed by a protecting reaction of a hydroxyl group to convert it to a compound represented by formula (I): (wherein X represents an optionally protected hydroxyl group) and then subjecting the compound to a one-carbon adding reaction to convert it to (2R)-2-propyloctanamide, followed by recrystallization and hydrolysis. According to the process of the present invention, (2R)-2-propyloctanoic acid can be produced by less steps as compared with the conventional method without a dangerous reaction.Type: ApplicationFiled: June 9, 2004Publication date: June 22, 2006Inventors: Yasumasa Hamada, Tomoyuki Hasegawa, Toshiaki Matsui, Eiji Kasamatsu
-
Publication number: 20050004096Abstract: Indole derivatives represented by formula (I) wherein all symbols represent the same as that in specification), production methods thereof, and DP receptor antagonist comprising them as active ingredients. Since the compounds of formula (I) binds and antagonizes to DP receptor, they are useful for the prevention and/or treatment against allergic diseases, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, cerebrovascular disorder, pleuritis complicated by rheumatoid arthritis, ulcerative colitis.Type: ApplicationFiled: September 6, 2002Publication date: January 6, 2005Inventors: Kazuhiko Torisu, Tomoyuki Hasegawa, Kaoru Kobayashi, Fumio Nambu
-
Publication number: 20040092750Abstract: 2-Methylindole-4-acetic acid, which is represented by the formula (I) and is an intermediate for an important indole derivative as medicines; and a process for producing the compound and the synthetic intermediates.Type: ApplicationFiled: August 29, 2003Publication date: May 13, 2004Inventors: Tomoyuki Hasegawa, Yasufumi Kawanaka
-
Publication number: 20030036921Abstract: The consultant server and the consultation method are provided for fixing a user's fee and a rating for each service, notifying the user of the information, and allocating the user's fee among service providers based on the rating when a user obtains a service via the Internet. The consultant server includes a sending/receiving device by which evaluation information input by a user who has obtained a service, a information-processing device which fixes a user's fee and a rating for each service based on the evaluation information, a sending/receiving device which sends information about the above described user's fee and rating for each service to a user's personal computer and the like, an information-processing device which allocates user's fees for services among service providers based on the rating.Type: ApplicationFiled: August 15, 2002Publication date: February 20, 2003Inventors: Atsushi Ito, Tomoyuki Hasegawa, Iwao Kawashima, Kanji Nakanishi, Koki Okamura, Norihisa Haneda